357 related articles for article (PubMed ID: 15777973)
1. Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction.
Sueoka E; Sueoka N; Iwanaga K; Sato A; Suga K; Hayashi S; Nagasawa K; Nakachi K
Lung Cancer; 2005 Apr; 48(1):77-83. PubMed ID: 15777973
[TBL] [Abstract][Full Text] [Related]
2. [Comparative quantification of plasma hnRNP B1 mRNA in non-small cell lung cancer patients by real-time PCR].
Kim JM; Hwang SH; Song EJ; Lee SY; Kim YD; Lee CH; Lee MK; Chang CL; Lee EY
Korean J Lab Med; 2009 Jun; 29(3):249-55. PubMed ID: 19571624
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer.
Zech VF; Dlaska M; Tzankov A; Hilbe W
Cancer Detect Prev; 2006; 30(5):395-402. PubMed ID: 17067748
[TBL] [Abstract][Full Text] [Related]
4. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression.
Tockman MS; Mulshine JL; Piantadosi S; Erozan YS; Gupta PK; Ruckdeschel JC; Taylor PR; Zhukov T; Zhou WH; Qiao YL; Yao SX
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2237-46. PubMed ID: 9815620
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers.
Sueoka E; Goto Y; Sueoka N; Kai Y; Kozu T; Fujiki H
Cancer Res; 1999 Apr; 59(7):1404-7. PubMed ID: 10197602
[TBL] [Abstract][Full Text] [Related]
6. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.
Miura N; Nakamura H; Sato R; Tsukamoto T; Harada T; Takahashi S; Adachi Y; Shomori K; Sano A; Kishimoto Y; Ito H; Hasegawa J; Shiota G
Cancer Sci; 2006 Dec; 97(12):1366-73. PubMed ID: 17052260
[TBL] [Abstract][Full Text] [Related]
7. hnRNP B1 expression in benign and malignant lung disease.
Snead DR; Perunovic B; Cullen N; Needham M; Dhillon DP; Satoh H; Kamma H
J Pathol; 2003 May; 200(1):88-94. PubMed ID: 12692846
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of hnRNPA2/B1 in bronchoscopic specimens: a potential early detection marker in lung cancer.
Katsimpoula S; Patrinou-Georgoula M; Makrilia N; Dimakou K; Guialis A; Orfanidou D; Syrigos KN
Anticancer Res; 2009 Apr; 29(4):1373-82. PubMed ID: 19414390
[TBL] [Abstract][Full Text] [Related]
9. [RNA interference of hnRNP B1 gene in human A549 lung cells].
Pu D; Zhou TY; Li WM; Wu D; Chen XB; Chen M; Tang FM; Han J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):805-7. PubMed ID: 19024319
[TBL] [Abstract][Full Text] [Related]
10. [Effects of hnRNP B1-specific siRNA on the expression of hnRNP B1 in lung cancer tissues in vivo].
Wen CS; Li WM; Pu D; Chen WB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):808-11. PubMed ID: 19024320
[TBL] [Abstract][Full Text] [Related]
11. Methylation of RAS association domain family protein 1A as a biomarker of lung cancer.
Grote HJ; Schmiemann V; Geddert H; Bocking A; Kappes R; Gabbert HE; Sarbia M
Cancer; 2006 Apr; 108(2):129-34. PubMed ID: 16444703
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of splicing factor, heterogeneous nuclear ribonucleoprotein A2/B1, in mouse lung neoplasia.
Peebles KA; Dwyer-Nield LD; Malkinson AM
Mol Carcinog; 2007 Nov; 46(11):887-900. PubMed ID: 17477362
[TBL] [Abstract][Full Text] [Related]
13. [Role of heterogeneous nuclear ribonucleoprotein A2/B1 protein in the pathogenesis of non-small cell lung cancer].
Shi Y; Chen Y; Hou YY; Ji CH; Hu Q; Zhou Y; Su JA; Tan YS
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):110-4. PubMed ID: 21575478
[TBL] [Abstract][Full Text] [Related]
14. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
[TBL] [Abstract][Full Text] [Related]
15. Quantification of free RNA in serum and bronchial lavage: a new diagnostic tool in lung cancer detection?
Schmidt B; Engel E; Carstensen T; Weickmann S; John M; Witt C; Fleischhacker M
Lung Cancer; 2005 Apr; 48(1):145-7. PubMed ID: 15777983
[TBL] [Abstract][Full Text] [Related]
16. Expression of hnRNP B1 in four major histological types of lung cancers.
Hamasaki M; Kamma H; Wu W; Kaneko S; Fujiwara M; Satoh H; Haraoka S; Kikuchi M; Shirakusa T
Anticancer Res; 2001; 21(2A):979-84. PubMed ID: 11396191
[TBL] [Abstract][Full Text] [Related]
17. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
[TBL] [Abstract][Full Text] [Related]
18. Combined detection of CEA, CK-19 and c-met mRNAs in peripheral blood: a highly sensitive panel for potential molecular diagnosis of non-small cell lung cancer.
Sheu CC; Chang MY; Chang HC; Tsai JR; Lin SR; Chang SJ; Hwang JJ; Huang MS; Chong IW
Oncology; 2006; 70(3):203-11. PubMed ID: 16809939
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous nuclear ribonucleoprotein B1 as early cancer biomarker for occult cancer of human lungs and bronchial dysplasia.
Sueoka E; Sueoka N; Goto Y; Matsuyama S; Nishimura H; Sato M; Fujimura S; Chiba H; Fujiki H
Cancer Res; 2001 Mar; 61(5):1896-902. PubMed ID: 11280744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]